The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
DANNCE.AI Raises $2.6 Million for AI Biomarkers Platform
Nov 21, 2024•over 1 year ago
Contract Type
partnership
BostonBiotechnologyHealth Care
Description
DANNCE.AI raised $2.6 million in pre-seed funding to bring to market DANNCE, a novel phenotyping platform to digitize clinical assessments used by doctors and therapeutic developers to quantify movement and automatically analyze them for evidence of neurological disease. This platform represents a paradigm shift from the current standard of care.
Company Information
Company
DANNCE.ai
Location
Boston, Massachusetts, United States
About
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DANNCE will help clinicians see the unseeable and drug developers generate real world evidence by using movement data and computer vision.
BostonBiotechnologyHealth Care